Form D · Biotechnology
LifEngine Animal Health Laboratories Inc
Rochester, MN · CIK 0001782895
Offering snapshot reported Dec 3, 2019 · SEC filing
- Reported sold
- $53K Offering amount: $1.07M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Nov 7, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 3, 2019 | Initial | $53,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-354591
Source: Form D, filed Dec 3, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Wesley Wierson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
14 4 Th Street Southwest Suite 203
Rochester, MN, 55902
Rochester, MN, 55902